To date, studies have shown that in TB patients given effective anti-TB treatment, IFN-γ levels decrease while IL-2 levels increase [26, 27], and these changes in the cytokine profile suggest effective NBXH treatment. The gene discussed is IL2; the disease is tuberculosis.